NF1 and neoplasm: We propose that the biological significance of these observations is two-fold: (i) tovorafenib alone is insufficient to prevent tumor growth in the NF1-LOF setting and (ii) in the NF1-LOF setting, there is a potential risk of increased tumor growth in response to tovorafenib, as indicated by the NF1-LOF GEMM data (29).